- Home
- LPCN vs SIF Comparison
LPCN vs SIF Comparison
Compare LPCN & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SIF
- Stock Information
- Founded
- LPCN 1997
- SIF 1913
- Country
- LPCN United States
- SIF United States
- Employees
- LPCN N/A
- SIF N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SIF Office Equipment/Supplies/Services
- Sector
- LPCN Health Care
- SIF Industrials
- Exchange
- LPCN Nasdaq
- SIF Nasdaq
- Market Cap
- LPCN 16.1M
- SIF 18.6M
- IPO Year
- LPCN N/A
- SIF N/A
- Fundamental
- Price
- LPCN $3.29
- SIF $3.35
- Analyst Decision
- LPCN Strong Buy
- SIF
- Analyst Count
- LPCN 2
- SIF 0
- Target Price
- LPCN $9.00
- SIF N/A
- AVG Volume (30 Days)
- LPCN 59.4K
- SIF 20.2K
- Earning Date
- LPCN 08-07-2025
- SIF 08-11-2025
- Dividend Yield
- LPCN N/A
- SIF N/A
- EPS Growth
- LPCN N/A
- SIF N/A
- EPS
- LPCN N/A
- SIF N/A
- Revenue
- LPCN $3,674,834.00
- SIF $83,554,000.00
- Revenue This Year
- LPCN N/A
- SIF N/A
- Revenue Next Year
- LPCN N/A
- SIF N/A
- P/E Ratio
- LPCN N/A
- SIF N/A
- Revenue Growth
- LPCN N/A
- SIF 35.83
- 52 Week Low
- LPCN $2.68
- SIF $2.33
- 52 Week High
- LPCN $8.71
- SIF $5.96
- Technical
- Relative Strength Index (RSI)
- LPCN 51.52
- SIF 47.84
- Support Level
- LPCN $3.13
- SIF $3.56
- Resistance Level
- LPCN $3.53
- SIF $3.78
- Average True Range (ATR)
- LPCN 0.24
- SIF 0.26
- MACD
- LPCN 0.01
- SIF -0.05
- Stochastic Oscillator
- LPCN 48.33
- SIF 33.61
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.